ECSP055652A - Un nuevo proceso para la preparación de derivados de epotilona, nuevos derivados de epotilona, así como nuevos productos intermediarios para el proceso, y los métodos para su preparación - Google Patents

Un nuevo proceso para la preparación de derivados de epotilona, nuevos derivados de epotilona, así como nuevos productos intermediarios para el proceso, y los métodos para su preparación

Info

Publication number
ECSP055652A
ECSP055652A EC2005005652A ECSP055652A ECSP055652A EC SP055652 A ECSP055652 A EC SP055652A EC 2005005652 A EC2005005652 A EC 2005005652A EC SP055652 A ECSP055652 A EC SP055652A EC SP055652 A ECSP055652 A EC SP055652A
Authority
EC
Ecuador
Prior art keywords
new
preparation
epotilone
derivatives
methods
Prior art date
Application number
EC2005005652A
Other languages
English (en)
Inventor
Olivier Loiseleur
Guido Koch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP055652(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP055652A publication Critical patent/ECSP055652A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención proporciona una síntesis para la preparación de derivados de epotilona de la fórmula 9, en donde: R1 es metilo, y R2 tiene el significado de un arilo insustituido o sustituido, un heteroarilo insustituido o sustituido, o un radical heterocíclico insustituido o sustituido fusionado con un núcleo de benceno, y sales de los mismos, e intermediarios para la síntesis de un compuesto de la fórmula 9.
EC2005005652A 2002-09-13 2005-03-09 Un nuevo proceso para la preparación de derivados de epotilona, nuevos derivados de epotilona, así como nuevos productos intermediarios para el proceso, y los métodos para su preparación ECSP055652A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221312.2A GB0221312D0 (en) 2002-09-13 2002-09-13 Organic compounds

Publications (1)

Publication Number Publication Date
ECSP055652A true ECSP055652A (es) 2005-05-30

Family

ID=9944042

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005652A ECSP055652A (es) 2002-09-13 2005-03-09 Un nuevo proceso para la preparación de derivados de epotilona, nuevos derivados de epotilona, así como nuevos productos intermediarios para el proceso, y los métodos para su preparación

Country Status (29)

Country Link
US (1) US7470792B2 (es)
EP (1) EP1539768B1 (es)
JP (1) JP4628102B2 (es)
KR (1) KR20050042500A (es)
CN (1) CN100522968C (es)
AR (1) AR041231A1 (es)
AT (1) ATE373663T1 (es)
AU (2) AU2003267349B2 (es)
BR (1) BR0314263A (es)
CA (1) CA2497119C (es)
CY (1) CY1107794T1 (es)
DE (1) DE60316456T2 (es)
DK (1) DK1539768T3 (es)
EC (1) ECSP055652A (es)
ES (1) ES2290489T3 (es)
GB (1) GB0221312D0 (es)
IL (1) IL166829A (es)
MX (1) MXPA05002785A (es)
MY (1) MY140442A (es)
NO (1) NO20051794L (es)
NZ (1) NZ538612A (es)
PE (1) PE20050052A1 (es)
PL (1) PL375039A1 (es)
PT (1) PT1539768E (es)
RU (2) RU2343155C2 (es)
SG (1) SG155770A1 (es)
TW (1) TWI289563B (es)
WO (1) WO2004024735A2 (es)
ZA (1) ZA200501008B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386922B1 (en) 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CA2927832C (en) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU716610B2 (en) * 1996-08-30 2000-03-02 Novartis Ag Method for producing epothilones, and intermediate products obtained during the production process
US6380394B1 (en) * 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
EP0975638B1 (de) * 1997-02-25 2002-08-07 Gesellschaft für biotechnologische Forschung mbH (GBF) Seitenkettenmodifizierte epothilone
US6498257B1 (en) * 1998-04-21 2002-12-24 Bristol-Myers Squibb Company 2,3-olefinic epothilone derivatives
GB9810659D0 (en) * 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
BR9916833A (pt) * 1998-12-22 2001-09-25 Novartis Ag Derivados de epotilona e seu uso como agentes antitumor
EP1226142A2 (en) * 1999-07-22 2002-07-31 Schering Aktiengesellschaft Process for the production of epothiolone b and derivatives as well as intermediate products for this process
US6593115B2 (en) * 2000-03-24 2003-07-15 Bristol-Myers Squibb Co. Preparation of epothilone intermediates
US6989450B2 (en) * 2000-10-13 2006-01-24 The University Of Mississippi Synthesis of epothilones and related analogs
KR20050026033A (ko) 2002-07-31 2005-03-14 쉐링 악티엔게젤샤프트 신규 효과기 접합체, 그의 제조 방법 및 그의 약학적 용도

Also Published As

Publication number Publication date
US7470792B2 (en) 2008-12-30
SG155770A1 (en) 2009-10-29
PL375039A1 (en) 2005-11-14
CY1107794T1 (el) 2013-06-19
TWI289563B (en) 2007-11-11
BR0314263A (pt) 2005-07-05
CN100522968C (zh) 2009-08-05
NZ538612A (en) 2008-01-31
AR041231A1 (es) 2005-05-11
AU2003267349B2 (en) 2008-05-01
AU2008203451A1 (en) 2008-08-21
IL166829A (en) 2011-01-31
EP1539768B1 (en) 2007-09-19
RU2343155C2 (ru) 2009-01-10
HK1078853A1 (en) 2006-03-24
NO20051794D0 (no) 2005-04-12
DK1539768T3 (da) 2008-01-07
RU2005110925A (ru) 2006-01-20
TW200413388A (en) 2004-08-01
PE20050052A1 (es) 2005-03-28
ES2290489T3 (es) 2008-02-16
ZA200501008B (en) 2006-12-27
MXPA05002785A (es) 2005-06-03
CA2497119C (en) 2011-08-02
CA2497119A1 (en) 2004-03-25
WO2004024735A2 (en) 2004-03-25
RU2008129613A (ru) 2010-01-27
EP1539768A2 (en) 2005-06-15
DE60316456T2 (de) 2008-06-19
MY140442A (en) 2009-12-31
NO20051794L (no) 2005-04-12
DE60316456D1 (de) 2007-10-31
KR20050042500A (ko) 2005-05-09
CN1681824A (zh) 2005-10-12
WO2004024735A3 (en) 2004-07-22
RU2404985C2 (ru) 2010-11-27
PT1539768E (pt) 2007-12-17
ATE373663T1 (de) 2007-10-15
JP4628102B2 (ja) 2011-02-09
JP2006511469A (ja) 2006-04-06
US20060106073A1 (en) 2006-05-18
AU2003267349A1 (en) 2004-04-30
GB0221312D0 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
AR055144A1 (es) Inhibidor de secrecion acida
CY1110434T1 (el) Παραγωγα ν-πυρρολιδιν-3-υλ-αμιδιου ως αναστολεις επαναπροσληψεως σεροτονινης και νοραδρεναλινης
NO20082243L (no) Fremgangsmater og forbindelser for fremstiliing av CC-1065 analoger
CY1115103T1 (el) Μεθοδος παρασκευης παραγωγου αμινοθειαζολιου και παραγωγη ενδιαμεσου
EA200601852A1 (ru) Тетрагидрохинолиновые производные и способ их получения
CO5640117A2 (es) Derivados de 2,4-diamonopirimidina
UY31940A (es) Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones
BRPI0516905A (pt) processo para a preparação de um derivado n-[2-(2-piridinil)etil]carboxamida e compostos
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
CY1114927T1 (el) Νεα 2-υποκατεστημενα παραγωγα μεθυλο πεναμης
AR070263A1 (es) Derivados de oxazepinopirimidinona arilamido sustituidos, utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, medicamentos que los contienen y proceso de preparacion e intermediarios.
BRPI0516904A (pt) processo para a preparação de um derivado de 2-etilaminopiridina e composto
CY1105784T1 (el) Εκδοχα της πιπepαζινυλακυλπιπepιδινης η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη
AR058701A1 (es) Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos
AR049418A1 (es) Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes.
ECSP045420A (es) Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos
MX2022002362A (es) Derivado de 2-aminoquinazolinona.
CO4950515A1 (es) Nuevos derivados de la quinolina para uso medicinal
ECSP034504A (es) Derivados de acido oxazolil-arilpropionico y su uso como agonista ppar
AR045326A1 (es) Derivados de aminoquinolina y su uso como ligandos a3 de adenosina
AR059375A1 (es) Procedimiento para produccion de 5-alcoxi-4-hidroximetilpirazol y compuestos
SE9703379D0 (sv) New compounds
ATE446948T1 (de) Alpha-ketoamidderivativ, herstellungsverfahren und verwendung davon
CY1107794T1 (el) Νeα μeθοδος παρασκευhς παραγωγων εποθιλονης
IL186832A0 (en) Process for the preparation of a carboxamide derivatives